Status:
RECRUITING
Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
National Research Council of Thailand
Conditions:
Hpv
Eligibility:
FEMALE
12-45 years
Brief Summary
To assess the effectiveness of HPV vaccine 2 doses or less to prevent HPV high risk infection among adolescents and adults. We conduct the test-negative control study including 12-45 women who interes...
Eligibility Criteria
Inclusion
- Women aged 12-45 who willing to do HPV test check-up.
- Subject has provided written informed consent prior to performance of any study-specific procedures and is willing and has means to be contacted and to contact the investigator during the study.
- Based on clinical judgment, the participant with underlying chronic disease who has stable and well-controlled medical conditions.
Exclusion
- Participant with history of total hysterectomy and loop electrosurgical excision procedure.
- Participant who received 3 doses HPV vaccine.
- Any condition that might confound the interpretation of vaccine effectiveness by investigator
Key Trial Info
Start Date :
March 29 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT06220747
Start Date
March 29 2024
End Date
June 1 2025
Last Update
October 9 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Bangkok, Select..., Thailand, 10400
2
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi,
Bangkok, Thailand, 10400